文献速递白血病

全转录组RNA测序用于急性髓系白血病综合诊断

Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing.
PubMed 文献 · Leukemia · 2020-03-03

本研究开发了HAMLET生物信息学流程,通过全转录组RNA测序同时检测融合基因、小变异、串联重复和基因表达,在100例AML中验证。结果显示融合基因和EVI1过表达均准确检出,13个基因小变异灵敏度99.2%、特异度100%,FLT3和KMT2A串联重复灵敏度100%、特异度97.1%。

要点

  • HAMLET可单平台同时检测融合基因、小变异、串联重复和基因表达。
  • 13个AML常见突变基因小变异检测灵敏度99.2%、特异度100%。
  • FLT3和KMT2A串联重复检测灵敏度100%、特异度97.1%。

核心结论

  • HAMLET有潜力在单一技术平台上为AML分类、风险评估和靶向治疗提供准确的综合诊断信息。

研究设计与样本

  • 研究对100例AML病例进行全转录组RNA测序,并以参考方法和靶向重测序验证HAMLET结果。

主要发现

  • HAMLET准确检测所有融合基因和EVI1过表达,不受3q26异常影响。
  • 13个AML常见突变基因小变异检测灵敏度99.2%、特异度100%。
  • 基于soft-clipped reads的新算法检测FLT3和KMT2A串联重复,灵敏度100%、特异度97.1%。

关键数值与推荐

  • 13个AML常见突变基因小变异:灵敏度99.2%,特异度100%。
  • FLT3和KMT2A串联重复:灵敏度100%,特异度97.1%。

临床怎么用

  • HAMLET可作为AML诊断的单一综合平台,整合融合基因、小变异、串联重复和表达信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute myeloid leukemia (AML) is caused by genetic aberrations that also govern the prognosis of patients and guide risk-adapted and targeted therapy. Genetic aberrations in AML are structurally diverse and currently detected by different diagnostic assays. This study sought to establish whole transcriptome RNA sequencing as single, comprehensive, and flexible platform for AML diagnostics. We developed HAMLET (Human AML Expedited Transcriptomics) as bioinformatics pipeline for simultaneous detection of fusion genes, small variants, tandem duplications, and gene expression with all information assembled in an annotated, user-friendly output file. Whole transcriptome RNA sequencing was performed on 100 AML cases and HAMLET results were validated by reference assays and targeted resequencing. The data showed that HAMLET accurately detected all fusion genes and overexpression of EVI1 irrespective of 3q26 aberrations. In addition, small variants in 13 genes that are often mutated in AML were called with 99.2% sensitivity and 100% specificity, and tandem duplications in FLT3 and KMT2A were detected by a novel algorithm based on soft-clipped reads with 100% sensitivity and 97.1% specificity. In conclusion, HAMLET has the potential to provide accurate comprehensive diagnostic information relevant for AML classification, risk assessment and targeted therapy on a single technology platform.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Arindrarto W, Borràs DM, de Groen RAL, et al. Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing. Leukemia. 2020. PMID: 32127641. doi:10.1038/s41375-020-0762-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。